@article{be016db2a68d440da0a87aaadedcb20d,
title = "Intermediate-Risk Meningioma: Initial Outcomes from NRG Oncology/RTOG-0539",
author = "L. Rogers and P. Zhang and M.A. Vogelbaum and A. Perry and L. Ashby and J. Modi and A. Alleman and J.M. Galvin and D. Brachman and J.M. Jenrette and J. DeGroot and J.A. Bovi and M. Werner-Wasik and J.P.S. Knisely and M.P. Mehta",
note = "Author Disclosure: L. Rogers: None. P. Zhang: None. M.A. Vogelbaum: Consultant; Neuralstem, Inc., Pharmicokinesis, Inc. Chief Medical Officer and patent interests; Infuseon Therapeutics. Stock Options; Infuseon Therapeutics. Co-Chair; NRG. A. Perry: None. L. Ashby: Speaker's Bureau; Novocure, Arbor Pharmaceuticals. J. Modi: None. A. Alleman: None. J.M. Galvin: None. D. Brachman: None.",
year = "2015",
month = nov,
day = "1",
doi = "10.1016/j.ijrobp.2015.07.331",
language = "American English",
volume = "93",
journal = "International Journal of Radiation Oncology Biology Physics",
}